Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 1
2015 1
2016 3
2017 5
2018 7
2019 4
2020 4
2021 12
2022 7
2023 3
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project.
Arnold N, Blaum C, Goßling A, Brunner FJ, Bay B, Ferrario MM, Brambilla P, Cesana G, Leoni V, Palmieri L, Donfrancesco C, Padró T, Andersson J, Jousilahti P, Ojeda F, Zeller T, Linneberg A, Söderberg S, Iacoviello L, Gianfagna F, Sans S, Veronesi G, Thorand B, Peters A, Tunstall-Pedoe H, Kee F, Salomaa V, Schnabel RB, Kuulasmaa K, Blankenberg S, Koenig W, Waldeyer C. Arnold N, et al. Among authors: waldeyer c. Eur Heart J. 2024 Mar 27;45(12):1043-1054. doi: 10.1093/eurheartj/ehad867. Eur Heart J. 2024. PMID: 38240386
Inflammation and Cardiovascular Disease: The Future.
Arnold N, Lechner K, Waldeyer C, Shapiro MD, Koenig W. Arnold N, et al. Among authors: waldeyer c. Eur Cardiol. 2021 May 17;16:e20. doi: 10.15420/ecr.2020.50. eCollection 2021 Feb. Eur Cardiol. 2021. PMID: 34093741 Free PMC article. Review.
Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart Disease.
Arnold N, Blaum C, Goßling A, Brunner FJ, Bay B, Zeller T, Ferrario MM, Brambilla P, Cesana G, Leoni V, Palmieri L, Donfrancesco C, Ojeda F, Linneberg A, Söderberg S, Iacoviello L, Gianfagna F, Costanzo S, Sans S, Veronesi G, Thorand B, Peters A, Tunstall-Pedoe H, Kee F, Salomaa V, Schnabel RB, Kuulasmaa K, Blankenberg S, Waldeyer C, Koenig W; BiomarCaRE Investigators. Arnold N, et al. Among authors: waldeyer c. J Am Coll Cardiol. 2024 Jul 9;84(2):165-177. doi: 10.1016/j.jacc.2024.04.050. J Am Coll Cardiol. 2024. PMID: 38960510
[Cost-benefit analysis of new lipid-lowering agents].
Blaum C, Arnold N, Waldeyer C. Blaum C, et al. Among authors: waldeyer c. Herz. 2022 Jun;47(3):236-243. doi: 10.1007/s00059-022-05116-8. Epub 2022 Apr 25. Herz. 2022. PMID: 35467096 Review. German.
Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary Support.
Becher PM, Schrage B, Sinning CR, Schmack B, Fluschnik N, Schwarzl M, Waldeyer C, Lindner D, Seiffert M, Neumann JT, Bernhardt AM, Zeymer U, Thiele H, Reichenspurner H, Blankenberg S, Twerenbold R, Westermann D. Becher PM, et al. Among authors: waldeyer c. Circulation. 2018 Nov 13;138(20):2298-2300. doi: 10.1161/CIRCULATIONAHA.118.036691. Circulation. 2018. PMID: 30571518 No abstract available.
53 results